Anti-cancer spirocyclic-guanidine compounds and uses thereof

US12410141B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12410141-B2
Application numberUS-202117925923-A
CountryUS
Kind codeB2
Filing dateMay 18, 2021
Priority dateMay 18, 2020
Publication dateSep 9, 2025
Grant dateSep 9, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention of the instant application discloses spirocyclic guanidine compounds of general formula (I), shown below, and their use in methods of treating cancer

First claim

Opening claim text (preview).

The invention claimed is: 1. A compound selected from the group consisting of, 2. A method of treating cancer comprising administering a compound of claim 1 , wherein the cancer is selected from the group consisting of multiple myeloma, ovarian cancer, cervical cancer, breast cancer, liver cancer, and colon cancer. 3. The method of claim 2 , wherein the cancer is a liquid cancer or a solid cancer. 4. The method of claim 3 wherein the cancer is a solid cancer.

Assignees

Inventors

Classifications

  • Antineoplastic agents · CPC title

  • Spiro-condensed · CPC title

  • containing carbocyclic rings other than six-membered · CPC title

  • directly linked by a ring-member-to-ring-member bond · CPC title

  • C07D221/20Primary

    Spiro-condensed ring systems · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12410141B2 cover?
The invention of the instant application discloses spirocyclic guanidine compounds of general formula (I), shown below, and their use in methods of treating cancer
Who is the assignee on this patent?
Univ Johns Hopkins
What technology area does this patent fall under?
Primary CPC classification C07D221/20. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Sep 09 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).